what are the negative effects of glp 1 side GLP-1 agonists? GLP-1 Agonist: The Good, the
Description
We're not at "GLP-1s treat depression." We're at "GLP-1s are teaching us something profound about how the body and mind regulate each other and we need to pay careful attention to who benefits and who doesn't." That's worth being excited about
With antiamyloid antibodies Leqembi (lecanemab) and Kisunla (donanemab) now FDAapproved for early Alzheimers, attention is turning to combination strategies that address multiple disease pathways
on the healthcare industry.
Learn how 2026 renewals will test plan design, compliance, and cost controland what conversations to start with clients before coverage questions hit.
Not the commercials
